154
Views
4
CrossRef citations to date
0
Altmetric
Ovarian reserve in patients with chronic kidney disease stages 3–4

Assessment of ovarian reserve as an indicator of fertility and health consequences in patients with chronic kidney disease stages 3–4

, , , , &
Pages 944-948 | Received 21 Jan 2018, Accepted 02 May 2018, Published online: 19 Jun 2018

References

  • Verma AK, Rajbhar S, Mishra J, et al. Anti-mullerian hormone: a marker of ovarian reserve and its association with polycystic ovarian syndrome. J Clin Diagn Res. 2016;10:10–12.
  • Jamil Z, Fatima SS, Cheema Z, et al. Assessment of ovarian reserve: anti-mullerian hormone versus follicle stimulating hormone. J Res Med Sci. 2016;21:100.
  • Shaban MM, Abdel Moety GA. Role of ultrasonographic markers of ovarian reserve in prediction of IVF and ICSI outcome. Gynecol Endocrinol. 2014;30:290–293.
  • Meczekalski B, Czyzyk A, Kunicki M, et al. Fertility in women of late reproductive age: the role of serum anti-Müllerian hormone (AMH) levels in its assessment. J Endocrinol Investig. 2016;39:1259–1265.
  • Smith HW. Comparative physiology of the kidney. In: Smith HW, editor. The kidney: structure and function in health and disease. New York: Oxford Univ Pr; 1951. p. 520–574.
  • Davies DF, Shock NW. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Investig. 1950;29:496–507.
  • Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc. 1985;33:278–285.
  • Rowe JW, Andres R, Tobin JD, et al. The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol. 1976;31:155–163.
  • National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:1–266.
  • Levey AS, Coresh J, Balk E, et al. National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137–147.
  • Espersen T, Schmitz O, Hansen HE, et al. Ovulation in uremic women: the reproductive cycle in women on chronic hemodialysis. Int J Fertil. 1988;33:103–106.
  • Zachoval R, Jarabak J, Slatinska J, et al. Dynamics of fertility in patients on waiting list for kidney transplantation. Bratisl Lek Listy. 2013;114:711–715.
  • Holley JL, Schmidt RJ. Changes in fertility and hormone replacement therapy in kidney disease. Adv Chronic Kidney Dis. 2013;20:240–245.
  • Szkudlarek M, Woliński K, Sikorska D, et al. Hormonal disorders in patients with chronic kidney disease. Pt. I – The hypothalamus and pituitary; hypogonadism. Medical News. 2013;82:474–481.
  • Eckersten D, Giwercman A, Bruun L, Christensson A. Anti-Müllerian hormone, a Sertoli cell-derived marker, is decreased in plasma of male patients in all stages of chronic kidney disease. Andrology. 2015;3:1160–1164.
  • Mutlu MF, Erdem A. Evaluation of ovarian reserve in infertile patients. J Turk Ger Gynecol Assoc. 2012;13:196–203.
  • Sikora-Grabka E, Adamczak M, Kuczera P, et al. Serum anti-müllerian hormone concentration in young women with chronic kidney disease on hemodialysis, and after successful kidney transplantation. Kidney Blood Press Res. 2016;41:552–560.
  • Tobler KJ, Shoham G, Christianson MS, et al. Use of anti-mullerian hormone for testing ovarian reserve: a survey of 796 infertility clinics worldwide. J Assist Reprod Genet. 2015;32:1441–1448.
  • Ledger WL. Clinical utility of measurement of anti-mullerian hormone in reproductive endocrinology. J Clin Endocrinol Metab. 2010;95:5144–5154.
  • Mok CC, Chan PT, To CH. Anti-müllerian hormone and ovarian reserve in systemic lupus erythematosus. Arthritis Rheum. 2013;65:206–210.
  • Eckersten D, Giwercman A, Christensson A. Male patients with terminal renal failure exhibit low serum levels of antimüllerian hormone. Asian J Androl. 2015;17:149–153.
  • Kahapola-Arachchige KM, Hadlow N, Wardrop R, et al. Waiting for an elevated FSH – too late a marker of reduced ovarian reserve?. Aust N Z J Obstet Gynaecol. 2012;52:460–464.
  • Erdem A, Erdem M, Biberoğlu K, et al. Age-related changes in ovarian volume, antral follicle counts and basal FSH in women with normal reproductive health. J Reprod Med. 2002;47:835–840.
  • Kim JM, Song RK, Kim MJ, et al. Hormonal differences between female kidney transplant recipients and healthy women with the same gynecologic conditions. Transplant Proc. 2012;44:740–743.
  • Rath M, Ramachandran R. Sexual and gonadal dysfunction in chronic kidney disease: pathophysiology. Indian J Endocr Metab. 2012;16:214–219.
  • van Eps C, Hawley C, Jeffries J, et al. Changes in serum prolactin, sex hormones and thyroid function with alternate nightly nocturnal home haemodialysis. Nephrology (Carlton). 2012;17:42–47.
  • Menken J, Trussell J, Larsen U. Age and infertility. Science. 1986;233:1389–1394.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.